Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells - Wikidata - awgldk - TriplyDB

Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells

Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells

http://www.wikidata.org/entity/Q36562321

about

Biallelic insertion of a transcriptional terminator via the CRISPR/Cas9 system efficiently silences expression of protein-coding and non-coding RNA genes Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer High expression of long non-coding RNA NEAT1 indicates poor prognosis of human cancer.Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancer shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells.LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer.Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.Long Noncoding RNA PVT1 Promotes EMT and Cell Proliferation and Migration Through Downregulating p21 in Pancreatic Cancer Cells.Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma Quantitative Systems Biology to decipher design principles of a dynamic cell cycle network: the "Maximum Allowable mammalian Trade-Off-Weight" (MAmTOW).LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma.Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells Recent development on synthetic biological devices treating bladder cancer.Synthetic regulatory RNAs selectively suppress the progression of bladder cancer.Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2.Role of Non-Coding RNAs in the Etiology of Bladder Cancer.Long noncoding RNA PVT1 inhibits renal cancer cell apoptosis by up-regulating Mcl-1.lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression.Long non-coding RNA expression in bladder cancer.Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer.Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis.TPGLDA: Novel prediction of associations between lncRNAs and diseases via lncRNA-disease-gene tripartite graph.Long non-coding RNA HNF1A-AS1 promotes cell viability and migration in human bladder cancer.Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas.Emerging roles of long non-coding RNA in cancer.A tetracycline-inducible CRISPR/Cas9 system, targeting two long non-coding RNAs, suppresses the malignant behavior of bladder cancer cells Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway Network-Based Approaches to Explore Complex Biological Systems towards Network Medicine Downregulation of lncRNA PVT1 expression inhibits proliferation and migration by regulating p38 expression in prostate cancer

P2860

Q33567619-622AE2A0-C875-4B20-AA4A-74C678897546 Q33709621-9A20E4A8-F631-4546-947F-1D9B1ECAB9B7 Q36024243-FB3AED72-16E7-4EA5-A734-D805369EB6D0 Q36276986-7709B47F-CA39-46F8-B3A1-C2FBE38371CE Q36372620-2374293A-05DA-452B-9792-D458AE76CB30 Q37024604-DAE55F7B-1680-4669-BE69-82AF6BFB4325 Q37227918-130837FD-4769-4674-B3FF-1FED951388B7 Q37295271-F7F5EF5B-E447-4531-9B68-2FDF20B55DA2 Q37301723-978C2E46-6CDB-4BE7-8607-469316EEA183 Q37448230-B481E744-C7FB-46C2-9A8D-4522488FC6AC Q37665607-60DAF078-0E95-4B3F-991A-0656339962BA Q38709746-CBE1833B-EFA1-44E0-9435-1F25DEA18AE7 Q39432577-2A34CC6D-DA49-4EC8-B0E2-CC3AFA641365 Q41279969-7F013AB5-79F1-4B87-964C-2064056434AF Q41701607-65B8DFE1-FB10-46BD-8963-18C9E6EB18C6 Q41899411-9D5920DE-D723-4A5F-8CEE-B6CE8C262051 Q42654709-984F539C-AF27-4BD7-B5EA-E63E368DD2DE Q45873502-53DE176F-85E2-4A41-A478-61DEFBA8239C Q45902808-D4160820-B975-4738-A278-7EEC837ABF39 Q45980440-8B3CA193-DC7D-4AD7-84CC-85696D780ECB Q46236214-FE02BD1A-5EA2-4D45-8D59-9F58FB6D00A1 Q47114053-3BC104AA-7900-4763-8FB2-F44C9CF396CF Q47161849-D279EE8B-707B-4296-A2DE-6C275CD3A70E Q47339135-C4E00504-678E-45E3-A2F9-EE72C3D21DB8 Q47630151-B57D9D92-37DC-4305-AEA5-411232F95F1B Q47899728-ADF21FF5-9614-4227-B35F-AC3A7F9E3CE4 Q49210529-C08F50AF-11DE-4A91-9E22-898EBF29C9DD Q49307799-DAC8D22F-1D41-4043-8245-6B5F30DA6367 Q52655139-122628AE-BD21-4A07-A230-9C86831BCCCA Q52670837-16EE3E83-58A8-4929-BBAF-A249B732FAB3 Q55508261-CED7EE79-9FD3-4731-8D5D-543509640C58 Q57144483-71B28217-1785-4B0D-B2AE-83518ED9046B Q58693584-B18DC17C-8205-4DA5-B66E-801500B34C1B Q58779278-A89CD712-8BBC-4F4B-A12F-7056F8B34F53 Q58779753-EF33F7B2-6593-4347-A494-BA86AD13E91A

P2860

Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells

http://www.wikidata.org/entity/Q36562321

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Tetracycline-inducible shRNA t ...... ptosis in bladder cancer cells

@ast

Tetracycline-inducible shRNA t ...... ptosis in bladder cancer cells

@en

type

label

Tetracycline-inducible shRNA t ...... ptosis in bladder cancer cells

@ast

Tetracycline-inducible shRNA t ...... ptosis in bladder cancer cells

@en

prefLabel

Tetracycline-inducible shRNA t ...... ptosis in bladder cancer cells

@ast

Tetracycline-inducible shRNA t ...... ptosis in bladder cancer cells

@en

P1433

Q36562321-67531D6F-D1EB-4602-99CE-EDAAC0B93300

P1476

Q36562321-C5F8337C-B79D-4981-83E1-D2B64FE227BD

P2093

Q36562321-32BAC102-582A-46ED-93E0-C40DFE313EE4

Q36562321-3A0423FC-0667-42F8-A44A-19B768431428

Q36562321-4BF21B59-BD62-45A4-A0F0-4F06BCEAC17C

Q36562321-538C14D1-63B0-4B5A-A4DF-80430F49255B

Q36562321-54727D99-73B1-4B91-98C9-622B3388DA97

Q36562321-58A1FC71-BC8E-4E31-9D08-AE3CF62D00B7

Q36562321-788DBBB3-C6B6-415A-A868-A1CD3E39D2E5

Q36562321-87B3C6F8-1E09-4650-A2FE-065A9873F58D

Q36562321-B4D5A83E-1099-4CB6-92C4-D79807C19EA3

Q36562321-BA4B0F18-512B-458D-865E-683AE551F81E

P2860

Q36562321-02C025B5-E445-4500-B9F8-45C3936F8E76

Q36562321-049151E7-F633-4260-B0FF-AD81779D09F9

Q36562321-051C4AB4-3C62-4DEE-8CAB-70789CE6641E

Q36562321-08DC6E33-51DA-4A1D-A785-656495A02F45

Q36562321-0E223C59-CAA9-4583-94FC-B2E8DFD8B5E2

Q36562321-2AD6B2F9-FE00-4B9D-A661-B8E377C60B61

Q36562321-305E0DDB-C1FD-48C1-8C23-859131C446DC

Q36562321-371EFCAC-990C-4D64-82BB-6F840E16B0E8

Q36562321-3B6FF8E1-146F-4785-AD95-9C83ADCB2E97

Q36562321-40D3AB9A-389E-44EC-A8F3-67535902AC54

P304

Q36562321-81B8DF2E-78D2-4B32-9B78-A25543614F90

P31

Q36562321-661B7F40-BBBD-4424-8808-6E772CE9DA59

P356

Q36562321-F68DB070-C3A8-4893-BBE3-9A059573198C

P407

Q36562321-9453AFE7-B348-4750-9162-4A9D8A7F35A5

P433

Q36562321-D75E1EE7-0A3F-4DA2-A2F1-5D18E5A40DF1

P478

Q36562321-8FC8691F-A22C-4098-B246-8524CD535169

P577

Q36562321-62C6D012-AB2A-401D-BA22-B864995EF54E

P5875

Q36562321-21351027-2253-4F52-B385-EA3C446F76E5

P698

Q36562321-8948E4E5-879A-4DB3-8358-3965D6338948

P921

Q36562321-7A345DCC-47A6-455E-93C9-4D583F6D952D

P932

Q36562321-C298088C-B790-4B2F-B898-6986E31C6705

P356

ONCOTARGET.5880

P1433

P1476

Tetracycline-inducible shRNA t ...... ptosis in bladder cancer cells

@en

P2093

Chengle Zhuang

http://www.w3.org/2001/XMLSchema#string

Guoping Zhao

http://www.w3.org/2001/XMLSchema#string

Jiancheng Yuan

http://www.w3.org/2001/XMLSchema#string

Jianfa Li

http://www.w3.org/2001/XMLSchema#string

Junhao Lin

http://www.w3.org/2001/XMLSchema#string

Li Liu

http://www.w3.org/2001/XMLSchema#string

Mingwei Chen

http://www.w3.org/2001/XMLSchema#string

Qing Zhou

http://www.w3.org/2001/XMLSchema#string

Weiren Huang

http://www.w3.org/2001/XMLSchema#string

Wen Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Long noncoding RNA as modular scaffold of histone modification complexes

Cancer statistics, 2013

Whole-genome synthesis and characterization of viable S13-like bacteriophages

Evolution and functions of long noncoding RNAs

Pvt1-encoded microRNAs in oncogenesis.

Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer.

ISL1 promotes pancreatic islet cell proliferation.

Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes.

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

EdU, a new thymidine analogue for labelling proliferating cells in the nervous system.

P304

41194-41203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5880

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283443899

http://www.w3.org/2001/XMLSchema#string

P698

26517688

http://www.w3.org/2001/XMLSchema#string

P921

P932

4747399

http://www.w3.org/2001/XMLSchema#string